LOS ANGELES, CA, U.S.A, April 26, 2018 /EINPresswire.com/ -- The Pacific Mesothelioma Center (PMC) at the Pacific Heart, Lung & Blood Institute (PHLBI) is happy to announce the start of its new support group for mesothelioma patients. Nearly two years after the inception of its successful caregiver's group, the patient support group was created as a response to the growing number of individuals who expressed interest in a group centered on patients. The first meeting will be Wednesday, May 9th at 7 PM PST. The meeting will be held as a conference call every second Wednesday of the month through Uber Conference and will be moderated by PMC Nurse Practitioner and mesothelioma expert Lien Hua-Feng.

The support group will allow mesothelioma patients to discuss treatment experience with other patients, how to overcome side effects, share stories, and to ask questions about this rare cancer. Mesothelioma is an aggressive cancer caused by exposure to asbestos with few treatment options. It affects approximately 3,000 individuals in the United States each year, one-third of whom are veterans who were exposed to asbestos during military service. The rarity of this cancer limits the scope of the public’s awareness and funding for research into better treatment options.

The mission of the PMC is to generate hope through research, support, and education. The Pacific Mesothelioma Center is engaged in groundbreaking research to develop next-generation immunotherapies. PMC researchers have discovered an innovative approach to convert human mesenchymal stem cells (MSCs) into potent immune-boosting treatments that will pave the way for an entirely new class of immunotherapies that could be effective against a wide variety of cancer types, including the most aggressive ones like mesothelioma.

If you are a mesothelioma patient interested in participating on the call, please contact Christina McSherry at (310)-478-4678 or by email at christinam@phlbi.org.

Christina McSherry
The Pacific Mesothelioma Center
(310)-478-4678
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.